Introduction
Patients after organ transplantation are susceptible to infection by both pathogens and nonpathogens during immunosuppression. Most deaths after transplantation are due to infection (Rifkind et al. 1964 , Fulginiti et al. 1968 , Hill et al. 1967 . The incidence of tuberculosis in renal transplant recipients would appear to be low (Fulginiti et al. 1968 , Hil1et al. 1964 , Burgos-Chalderon et al. 1971 , Neff & H udgel 1973 , Rifkind et al. 1964 , and the disease is usually fatal (Rifkind et al. 1964 , Neff & Hudgel 1973 , Oliver 1976 .
Four cases of tuberculosis in immunosuppressed patients are presented; 2 of these had pulmonary tuberculosis and 2 had miliary tuberculosis. There have been no deaths; 2 have completed treatment and 2 are still undergoing treatment. Mycobacterium tuberculosis can no longer be demonstrated in any patient. No deterioration in renal function has been recorded.
Case reports
Case 1 A 31-year-old woman with no previous history of tuberculosis received a living related-donor kidney transplant in April 1972. Her immediate postoperative course was complicated by ureteric sloughing and generalized candidiasis. Both problems were treated successfully.
Three months after transplantation she complained of left-sided pleuritic pain. A chest xray revealed an opacity in the left upper zone and a left pleural effusion. Bacteriological examination of sputum, laryngeal swabs, blood, urine and gastric washings was negative for tuberculosis. A smear of pleural aspirate was negative on microscopy. Following thoracentesis, her pulmonary symptoms resolved. Azathioprine was discontinued for one month, owing to a decrease in the leukocyte count, and was subsequently reintroduced at a lower dose.
One month later, she suddenly developed confusion, disorientation, photophobia and severe occipital headaches. There was a swinging pyrexia but no focal neurological signs. Skull X-rays and brain scan were normal; EEG revealed a localized abnormality iIi the left temporooccipital region, either a chronic abscess, or part of a more widespread inflammatory process. Air encephalography revealed only a small degree of ventricular enlargement. Three lumbar punctures were performed: all revealed a lymphocytosis, but the first two were negative on microscopy. The third specimen, however, revealed Mycobacterium tuberculosis. By this time, the pleural aspirate was positive on culture. Antituberculous chemotherapy was commenced: para-aminosalicylic acid 12 g daily; isoniazid 400 mg daily; rifampicin 450 mg daily; and pyridoxine 100 mg daily. The neurological symptoms improved rapidly and the fever subsided over the next three weeks.
One month later, she developed an acute duodenal ulcer necessitating a vagotomy and pyloroplasty. At operation, a liver biopsy was taken which showed early cirrhotic changes, active chronic hepatitis and occasional granulomata containing acid-fast bacilli. Postoperatively, the antituberculous regime was changed to ethambutol 1.2 g daily, isoniazid 300 mg daily, rifampicin 600 mg daily and pyridoxine 50 mg daily. This regime was continued for a further three years. All subsequent laryngeal swabs and urine specimens remained negative, as did specimens of cerebrospinal fluid obtained one month, three months and three years after beginning treatment. Two years after the completion of treatment, she remains clinically well and free of tuberculosis. Throughout treatment, renal function was maintained.
Case 2 A 45-year-old man with no previous history of tuberculosis received a cadaveric renal transplant in April 1975 requiring postoperative haemodialysis. Five weeks later the transplant was functioning satisfactorily. There was a persistent low-grade pyrexia, but the patient remained asymptomatic.
Seven weeks after operation a chest X-ray revealed a small shadow in the left mid-zone which, on review of previous X-rays, may have been present for three months before operation. There was no evidence of tuberculosis on examination of sputum, laryngeal swabs, blood and urine, and he was therefore treated with broad-spectrum antibiotics. Two weeks later, a further X-ray showed that the lesion had cavitated and although cultures remained negative it was decided to commence anti-tuberculous chemotherapy with rifampicin 450 mg daily and isoniazid 100 mg daily.
The low-grade pyrexia persisted and hepatosplenomegaly was noticed. Further investigations, including examination ofbronchoscopically obtained brushings and aspirates, cerebrospinal fluid, bone marrow and liver biopsy did not reveal M. tuberculosis, but the liver biopsy showed cytomegalovirus which was not detected serologically. Liver function tests were normal. Therapy was continued with gradual increase ofthe dose of rifampicin to 600 mg daily and that of isoniazid to 300 mg daily. This regime was continued for I t years.
During the first six weeks of treatment the pulmonary lesion decreased in size and finally disappeared. One year after completion of treatment, he remains well and free of tuberculosis. Throughout treatment renal function was maintained.
Case 3 A 45-year-old man received a cadaveric renal transplant in April 1975. Postoperative progress was uneventful.
He was admitted in July 1977 with a one week history of general malaise, aches in arms, legs and back, dry cough and rhinorrhoea. On examination he appeared well but was pyrexial and examination of his chest revealed fine crepitations in all zones. A chest X-ray showed no evidence of active pulmonary disease although old apical calcification was noted. Bacteriological examination of sputum revealed M. tuberculosis, but examination of the blood and urine was negative. Antituberculous chemotherapy was commenced: rifampicin 600 mg daily; isoniazid 300 mg daily; ethambutol 1.6 g daily; and pyridoxine 20 mg daily. He remains on treatment.
His symptoms rapidly improved and M. tuberculosis disappeared from the sputum. Throughout treatment immunosuppressive therapy was unaltered and renal function was maintained.
Case 4 A 32-year-old man with no previous history of tuberculosis received a living related-donor kidney transplant in June 1976. Postoperative progress was uneventful.
In April 1977 he presented with a two month history of rigors culminating in a productive cough. On examination he was febrile, dehydrated and confused. He was mildly cyanosed and tachypnoeic with widespread crepitations in all zones. A chest X-ray showed dense patchy mottling affecting both lungs. Examination of sputum revealed acid-fast bacilli, but cultures of blood and urine were initially negative.
Antituberculous chemotherapy was commenced: streptomycin 1 g daily (for one month); rifampicin 600 mg daily; isoniazid 300 mg daily; and ethambutol 1.6 g daily. To cover secondary bacterial infection, broad spectrum antibiotics were given. His clinical condition improved rapidly but the radiographic appearances improved slowly. Within the first fortnight he became jaundiced (serum bilirubin 86 ]lmoljl, alanine transaminase III iujl). Both rifampicin and isoniazid were discontinued. Three weeks later, the jaundice had disappeared and the liver function tests returned to normal. Isoniazid was reintroduced at its previous dose and after a further two weeks rifampicin was reintroduced, gradually, to its previous dose. The liver function tests remained normal.
M. tuberculosis was subsequently isolated from blood and urine. Blood and sputum cultures became negative after two weeks, but urine cultures remained positive for a further month. With the persistent isolation of M. tuberculosis from urine, the urinary tract was investigated further. Excretory urography revealed a good nephrogram of the patient's right kidney (there was no left kidney) and of the transplant kidney. Cystoscopy revealed a normal bladder. Bacteriological examination of urine from each ureter was negative.
Therapy continues and he remains well. Throughout treatment renal function was maintained.
Discussion
Tuberculosis is one of the more serious infectious complications of renal transplantation. A low incidence has been reported previously: no cases in a series of 39 transplants, nor in a series of 17 transplants (Burgos-Chalderon et al. 1971 , Fulginiti et al. 1968 ; one case in a series of 30 transplants (Rifkind et al. 1964) ; and 2 cases in a series of 61 transplants (Hill et al. 1964) . Mortality has been reported to be high: one death in one case of tuberculosis (Rifkind et al. 1964 ); 2 deaths from 3 cases (Neff & HudgeI1973); and one death from 2 cases (Oliver 1976) . Cures reported are few (Oliver 1976 , Neff & Hudgel 1973 , Rattazzi et al. 1975 ) and in those cases reported, the incidence of deteriorating renal function is high.
The aetiology of tuberculosis in chronically immunosuppressed patients is believed to be usually a recrudescence of old, possibly previously asymptomatic, disease. Both azathioprine and corticosteroids have been implicated, but it would appear from studies on asthmatics receiving long-term corticosteroid therapy that corticosteroids do not reactivate tuberculosis (Smyllie & Connolly 1968) . Previously reported cases indicate that tuberculosis in the chronically immunosuppressed patient is not uncommonly miliary, and dissemination may occur rapidly after the first onset of symptoms (Oliver 1976 , Rattazzi et al. 1975 .
Pretransplantation tuberculin-testing has been proposed but there may be considerable problems with anergy -reactions being likely in 70% of all transplant recipients (Thomas & Manko 1975) . Prophylaxis with isoniazid has also been proposed, but it has been shown that isoniazid-related hepatic injury occurs in 8.2 cases per thousand of persons receiving chemoprophylaxis. This is likely to occur within eight weeks of commencement of isoniazid and may progress to death (Garibaldi et al. 1972) .
Of the 4 cases of tuberculosis in transplant recipients reported here, all have survived with good renal function. The time of presentation has been varied: 2 of the patients presented within three months of transplantation; one presented at ten months; and one presented more than two years after transplantation. Tuberculosis, therefore, may be regarded both as an early and as a late complication of immunosuppression. None of the 4 patients had any history of either active tuberculosis or of BCG immunization, although 2 had evidence of old tuberculosis. The presenting symptoms in all cases included a pyrexia of unknown origin, with 3 patients also having overt pulmonary symptoms.
In all 4 cases, there has been radiographic or microbiological evidence of pulmonary involvement; the 3 patients from whom M. tuberculosis was cultured all had the bacillus isolated from sputum or pleural fluid. In one case, despite rigorous investigation, tubercle bacilli were isolated only from sputum, but in 2 cases M. tuberculosis was isolated from other systems also. This emphasizes the miliary nature of tuberculosis in immunosuppressed patients, even though the patient may be asymptomatic. In cases of tuberculosis, therefore, it is essential to endeavour repeatedly to isolate M. tuberculosis from systems other than that from which primary isolation was made, whenever there is an unexplained pyrexia. All patients received rifampicin and isoniazid apart from other antituberculous chemotherapy, and only in one was there any evidence of hepatic damage -the abnormal liver function tests returning rapidly to within normal ranges on withdrawal of both of these drugs, with no subsequent deterioration of hepatic function upon their reintroduction. Our usual regime of corticosteroid therapy remained unaltered in all 4 patients and only in one (Case 2) was the dosage of azathioprine reduced significantly.
In none of the patients was there any evidence of deterioration of renal function and all transplants were functioning well at the completion of antituberculous chemotherapy or after persistent negative cultures.
Summary
Tuberculosis is a rare and usually fatal complication of renal transplantation. From 82 transplants in seven years, 4 cases of tuberculosis are reported. All have been treated successfully, with no fatalities or deterioration in renal function.
